ClinicalTrials.Veeva

Menu

Immunoregulation of Periodontal Disease

P

Public Assistance-Hospitals of Marseille (AP-HM)

Status

Completed

Conditions

Periodontal Disease

Treatments

Other: Blood sampling

Study type

Interventional

Funder types

Other

Identifiers

NCT00702429
2007-A00632-51

Details and patient eligibility

About

Our design is to test in hospital practice a selection of immune parameters that could assess the pathophysiology and progression of periodontal lesions.

Full description

These parameters will be measured in 25 healthy volunteers and 25 moderate-to severe periodontal disese patients. Phagocytes will be tested phenotypically and functionally, both ex vivo and in vitro.

Enrollment

23 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Persons appearing spontaneously at the consultation of parodontologie for parodontale disease,
  • persons agreeing to undergo a sampling of blood intended for the search

Exclusion criteria

  • Presence of a chronic or pointed pathology,
  • an age 18-year-old subordinate or 65-year-old superior,
  • pregnant women,

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

23 participants in 2 patient groups, including a placebo group

1
Experimental group
Description:
Patients achieve of parodontopathies
Treatment:
Other: Blood sampling
Other: Blood sampling
2
Placebo Comparator group
Description:
Patients without parodontales diseases
Treatment:
Other: Blood sampling
Other: Blood sampling

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems